GM20949 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic | ALG6, S. CEREVISIAE, HOMOLOG OF Skin, Unspecified Cell Line NTCC®细胞株-BioVector NTCC细胞库

Name细胞名称：NTCC® GM20949 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic | ALG6, S. CEREVISIAE, HOMOLOG OF Skin, Unspecified Cell Line
Ic 型先天性糖基化障碍 | ALG6，酿酒酵母，同源物细胞株
Description描述：Clinically affected; decreased fetal movements during pregnancy; birth weight = 3,500 g; spells of cyanosis and apnea during feeding in first 2 weeks of life; radiological evaluation showed bilateral reduction deformities of distal phalanges of digits II to IV in both hands and absence of the mid and distal phalanges on digits II to IV in the feet; right great toe has reduction of proximal phalanx and absence of distal phalanx; sat at 15 months, cruised at 3 years, walked independently at 5 years, first words at 5 years; 2 episodes of generalized epilepsy at age 20 months with normal EEG; grand mal seizures at ages 9 and 12 years; menarche at 15 years; irregular menses treated with medroxyprogesterone but followed by development of hirsutism; switched to triphasic contraceptive but excessive weight gain continued and male pattern frontal balding developed; pronounced virilization; deep vein thrombosis of left superficial femoral and deep popliteal vein developed at age 19 years; at 21 years, papilledema, as a result of pseudotumor cerebri, with normal venous MRI angiogram was noted; abdominal CT showed large ovaries with suspicion of multiple cysts; severe mental retardation; broad-based walk with kyphotic posture; normal muscle tone and deep tendon reflexes; dysmetria and intention tremor; distal phalangeal hypoplasia with small tapering nails, pointed distal digits, short distal phalanges and absent middle phalanx on the left second digit; normal brain MRI; abnormal coagulation factors: prothrombin time 11.4 sec (9.2-11.8), partial thromboplastin time 40.1 sec (20.6-32.9), antithrombin III 28 U/dl (88-131), Factor XI total 12.2 U/dl (52-120), protein C 24 U/dl (70-140), and protein S 42.2 U/dl (70-134); low LDL cholesterol of 44 mg/dl (62-136) but normal HDL cholesterol of 47 mg/dl (37-68); diagnosis confirmed using carbohydrate deficient transferrin analysis by electrospray ionization mass spectrometry; normal activities of phosphomannomutase, phosphomannose isomerase; donor subject is a compound heterozygote: one allele has a three base deletion in exon 9 of the ALG6 gene [897-899delAAT] that causes the loss of I299 and a second allele has an intronic mutation in intron 7 of the ALG6 gene [IVS7+2T>G] that disrupts splicing and causes skipping of exons 7-12 plus 22 bases of exon 13._x000D_
Category分类：Fibroblast
ID编号:NTCC®-GM20949
Size/Quantity数量: 1 Flask/2 Vials
Biosafety Level生物安全级别:1
Shipping Info运输方式: RT/Dry Ice
Storage储存方式: RT/Liquid Nitrogen
Race:
Age年龄:21 YR
Gender性别:Female
Cell Type细胞类型: CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic | ALG6, S. CEREVISIAE, HOMOLOG OF
Affected State:Yes
Product:Fibroblast
Gene:ALG6
Mutations突变:897_899delAAT IVS7+2T>G
Ethnicity:
Family:
Relationship:proband
Karyotype:
Tissue Type组织来源:Skin
Complete Growth Medium完全培养基: BioVector® Dulbecco Modified Eagles Medium (high glucose) with 2mM L-glutamine or equivalent Complete Medium
Subculturing传代方法:
Cryopreservation冻存方法:Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO
Storage temperature: liquid nitrogen vapor phase
Culture Conditions培养条件:Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37.0°C
STR Profile鉴定数据:
References参考文献:

Supplier供应商:BioVector质粒载体菌株细胞蛋白抗体基因保藏中心
NTCC典型培养物保藏中心
Tel电话：400-800-2947
Email：Biovector@163.com
http://www.biovector.net